• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Scientists uncover how protein clumps damage cells in Parkinson's

Bioengineer by Bioengineer
December 20, 2018
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Enzymes modify tau to create tau-alpha-synuclein clumps on mitochondria

IMAGE

Credit: Courtesy Scripps Research


JUPITER, FL – Biologists studying Parkinson’s disease have long hoped to solve the mystery of the telltale “clumps.” Scientists want to know how clumps of misfolded proteins damage brain cells and contribute to the disease.

Corinne Lasmézas, PhD, and her Scripps Research colleagues have now cracked the case of pα-syn*, a protein clump that is particularly toxic to the cells. Their recent study in the journal Neurobiology of Disease shows that pα-syn* causes damage by recruiting certain enzymes and an accomplice to damage cells. The accomplice is a protein called tau.

“We really felt like detectives in this study,” says Lasmézas, a professor on the Florida campus of Scripps Research. “We hope that this research into the root cause of Parkinson’s will bring us closer to finding a disease-modifying treatment.”

Parkinson’s disease is the most common neurodegenerative disease after Alzheimer’s. The disease strikes when the brain starts losing the cells that produce dopamine, a critical neurotransmitter.

Parkinson’s can have many causes, from genetics to environmental factors, but a protein called α-synuclein (α-syn in short) is found to turn bad and form clumps in every case. The Lasmézas lab has discovered that a particular type of α-syn clumps, or “aggregates,” that they called pα-syn*, starts to show up around cellular structures called mitochondria. This is a big problem for cells, which need mitochondria to produce their energy.

“We can see the mitochondria break into fragments in these cells,” says Lasmézas. “We wanted to understand the mechanism behind this.”

The investigation relied on a combination of cultured neurons and a mouse model of Parkinson’s, as well as analysis of donated brain tissues from deceased Parkinson’s disease patients.

The new research shows that pα-syn* hurts mitochondria by starting a cascade of events. First, pα-syn* activates a pathway in cells called the MAPK pathway. Enzymes of the MAPK pathway then modify the protein tau. This was a fascinating finding, since tau has long puzzled neuroscientists. Tau is known to form tangles inside neurons in the brains of Parkinson’s disease patients. But scientists did not know how they got there or what they were doing.

Lasmézas and her team found that enzymes of the MAPK pathway modify tau through a process called phosphorylation. This version of tau then clumps together with pα-syn* on the mitochondrial membrane. The two protein aggregates grow bigger and bigger, destroying the mitochondria in the process.

At last, the researchers knew what pα-syn* was doing and how it hurt cells. “We’ve shown how pα-syn* works as the main trigger in mitotoxicity,” says Lasmézas.

Study first author Diego Grassi, PhD, a research associate at Scripps Research at the time of the study, stresses the importance of discovering tau’s role in destroying mitochondria. Scientists know tau is involved in Alzheimer’s disease, so this study suggests a mechanism behind how Alzheimer’s and Parkinson’s overlap at the molecular level. The presence of α-syn and tau aggregates is also a telltale sign of other forms of dementia, and now scientists know how this might occur.

“This is also important for its possible implications in other neurodegenerative disorders,” says Grassi.

Lasmézas and Grassi say the next step in this research is to study how to stop pα-syn*, with the ultimate goal of treating Parkinson’s disease.

“I know we are doing something that could make a meaningful difference in the quality of life of people affected by this condition,” says Grassi. “I can hardly imagine a place better than Scripps Research to perform this kind of translational activity.”

###

Additional authors of the study, “Pα-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria,” were Natalia Diaz-Perez of Palm Beach Gardens and Laura A. Volpicelli-Daley of the University of Alabama at Birmingham.

Media Contact
Stacey Singer DeLoye
[email protected]
561-228-2551

Original Source

https://www.scripps.edu/news-and-events/press-room/2018/20181220-lasmezas.html

Tags: AlzheimerBiochemistryBiologyCell Biologyneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Kombucha’s Pharmaceutical Potential: Production, Patents, Challenges

August 10, 2025
blank

Surfactants and Oils Shape Emulsion Ripening Rates

August 10, 2025

Mulberry Vinegar Fights Cognitive Decline via NF-κB

August 9, 2025

Scientists Discover Novel Mechanism Behind Cellular Tolerance to Anticancer Drugs

August 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    139 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    78 shares
    Share 31 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    57 shares
    Share 23 Tweet 14
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Otoferlin Unveiled as Childhood Lupus Nephritis Biomarker

Desulfovibrio Strains Impact Neurodegeneration in C. elegans

Nanostructured Gd2O3: Synthesis Methods for Supercapacitors

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.